Tuesday, May 19, 2026

#biotech

7 articles

Vepdegestrant's 5-Month PFS Anchors Rigel-Arvinas-Pfizer Deal as Three PDUFA Dates Cluster in 2026

Biotech Dealmaking

Vepdegestrant's 5-Month PFS Anchors Rigel-Arvinas-Pfizer Deal as Three PDUFA Dates Cluster in 2026

Salvado•May 17, 2026

Novo Nordisk's 24.9% Stock Surge Validates Pharma's Pivot From Internal R&D to AI Partnerships

Pharma & Healthcare

Novo Nordisk's 24.9% Stock Surge Validates Pharma's Pivot From Internal R&D to AI Partnerships

Salvado•May 13, 2026

Alopecia Areata Market Poised for Expansion by 2036 as Novel Drug Classes Enter Pipeline

Pharmaceutical Markets

Alopecia Areata Market Poised for Expansion by 2036 as Novel Drug Classes Enter Pipeline

Salvado•Apr 26, 2026

NVIDIA Partners with Eli Lilly, Thermo Fisher to Build AI Drug Discovery Infrastructure

Corporate Strategy

NVIDIA Partners with Eli Lilly, Thermo Fisher to Build AI Drug Discovery Infrastructure

Salvado•Apr 13, 2026

NVIDIA Expands Biotech AI Infrastructure Through Partnerships with Thermo Fisher and Eli Lilly

Corporate Strategy

NVIDIA Expands Biotech AI Infrastructure Through Partnerships with Thermo Fisher and Eli Lilly

Salvado•Mar 25, 2026

Biotech's Commercial Inflection: What the Gene Therapy and mRNA Pipeline Surge Means for Investors

Healthcare Finance

Biotech's Commercial Inflection: What the Gene Therapy and mRNA Pipeline Surge Means for Investors

ViaNews Editorial Team (Finance)•Feb 18, 2026

Four Major Drug Trials Hit Key Milestones in Early 2026, Signaling Productive Clinical Research Cycle

Four Major Drug Trials Hit Key Milestones in Early 2026, Signaling Productive Clinical Research Cycle

ViaNews Editorial Team (Finance)•Feb 15, 2026